Clinical Trial

Tolerance to an Artisanal Bread in a Population Intolerant of the Conventional Bread and Study of Associated Markers

Study acronym: TOLERBREAD
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the effect of consuming an "artisanal" bread for 15 days on gastrointestinal symptoms in individuals intolerant to "conventional" bread. "Conventional bread" refers to bread made with refined wheat flour (ash = 0.55% of dry matter), containing gluten, and leavened with baker's yeast (Saccharomyces cerevisiae). "Artisanal bread" refers to bread made with whole wheat flour (ash = 1.50% of dry matter) from an ancient durum wheat variety (Russello) and leavened with sourdough.
Trial Details
NCT Number NCT07568223
Lead Sponsor Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Collaborators: UMR 914 PNCA - AgroParisTech, INRA, Université Paris-Saclay
Conditions Intolerance to "Conventional" Bread
Enrollment 40 participants
Start Date 2026-01-28
Primary Completion 2026-12 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-05